Investors

Insider Transactions

Date Sorted Descending Name Title Type Shares Traded Price Range
Apr 8, 2015 landry robert e Officer Option Execute 10,000 272.70
Mar 25, 2015 baker charles a Director Automatic Sell 5,000 452.45 - 457.21
Mar 25, 2015 baker charles a Director Option Execute 5,000 18.61
Mar 25, 2015 larosa joseph j Officer Option Execute 3,097 59.20
Mar 24, 2015 aberman michael s Officer Automatic Sell 4,843 474.79 - 482.56
Mar 23, 2015 aberman michael s Officer Automatic Sell 5,157 476.50
Mar 18, 2015 aberman michael s Officer Automatic Sell 3,442 462.84 - 472.14
Mar 17, 2015 aberman michael s Officer Automatic Sell 4,058 457.91
Mar 17, 2015 aberman michael s Officer Option Execute 11,398 24.00
Mar 17, 2015 terifay robert j Officer Automatic Sell 10,993 448.01 - 454.00
Mar 16, 2015 larosa joseph j Officer Automatic Sell 18,311 450.00
Mar 16, 2015 larosa joseph j Officer Option Execute 20,281 59.20
Mar 16, 2015 terifay robert j Officer Automatic Sell 13,382 444.46
Mar 16, 2015 terifay robert j Officer Option Execute 24,375 30.63
Feb 27, 2015 mccorkle douglas s Officer Sell 3,000 416.24
Feb 26, 2015 tessier-lavigne marc Director Sell 3,000 420.33 - 424.44
Feb 26, 2015 tessier-lavigne marc Director Option Execute 3,000 50.91
Feb 24, 2015 aberman michael s Officer Automatic Sell 3,374 416.31 - 420.64
Feb 24, 2015 terifay robert j Officer Automatic Sell 11,173 423.67
Feb 23, 2015 aberman michael s Officer Automatic Sell 4,126 427.94
Showing 41-60 of 974 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)